Murphy & Mullick Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Murphy & Mullick Capital Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$179K	Hold	364	–	–	0.13%	145
2025 Q4	$211K	Buy	364 +1	+0.3%	+$566	0.15%	133
2025 Q3	$176K	Hold	363	–	–	0.13%	155
2025 Q2	$169K	Hold	363	–	–	0.14%	145
2025 Q1	$181K	Hold	363	–	–	0.17%	120
2024 Q4	$189K	Buy	+363	New	+$200K	0.17%	118

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Murphy & Mullick Capital Management's TMO Position: Q1 2026 in Review

Murphy & Mullick Capital Management held its Thermo Fisher Scientific (TMO) position steady in Q1 2026 at 364 shares worth $179K. The position accounts for 0.13% of the portfolio, ranked #145.

Murphy & Mullick Capital Management first reported a position in TMO in Q4 2024 and has held it in 6 quarters since. The position peaked at $211K in Q4 2025. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Murphy & Mullick Capital Management held 364 shares of Thermo Fisher Scientific worth $179K as of Q1 2026.
Murphy & Mullick Capital Management left its Thermo Fisher Scientific share count unchanged in Q1 2026.
Thermo Fisher Scientific made up 0.13% of Murphy & Mullick Capital Management's portfolio in Q1 2026, its #145 holding.
Murphy & Mullick Capital Management first reported a position in Thermo Fisher Scientific in Q4 2024 and has held it in 6 quarters since.
Murphy & Mullick Capital Management's Thermo Fisher Scientific position peaked at $211K in Q4 2025.
2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Murphy & Mullick Capital Management's 13F filing for Q1 2026, filed 17 Apr 2026.